Annual Revenue
$82.00 M
+$55.09 M+204.75%
December 31, 2022
Summary
- As of February 10, 2025, JNCE annual revenue is $82.00 million, with the most recent change of +$55.09 million (+204.75%) on December 31, 2022.
- During the last 3 years, JNCE annual revenue has fallen by -$65.87 million (-44.55%).
Performance
JNCE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$82.00 M
NaN%
December 31, 2022
Summary
- As of February 10, 2025, JNCE quarterly revenue is $82.00 million
Performance
JNCE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$82.00 M
NaN%
December 31, 2022
Summary
- As of February 10, 2025, JNCE TTM revenue is $82.00 million
Performance
JNCE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
JNCE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +204.8% | - | - |
| 3 y3 years | -44.5% | - | - |
| 5 y5 years | +14.4% | +531.3% | - |
JNCE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -67.2% | at high | at low | at high | at low |
| 5 y | 5-year | -44.5% | -67.2% | at high | -98.1% | -8.1% | -24.0% |
| alltime | all time | -44.5% | -67.2% | -31.3% | -98.1% | -51.2% | -79.4% |
Jounce Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $82.00 M(+204.8%) | $82.00 M(+223.2%) | $82.00 M(-8.1%) |
| Dec 2021 | $26.91 M(-56.8%) | - | - |
| Jun 2021 | - | $25.37 M(+1548.3%) | $89.25 M(+39.7%) |
| Mar 2021 | - | $1.54 M(-97.5%) | $63.88 M(+2.5%) |
| Dec 2020 | $62.34 M(-57.8%) | $62.34 M(-47.8%) | $62.34 M(-62.9%) |
| Dec 2019 | $147.87 M(+126.8%) | - | - |
| Sep 2019 | - | $119.44 M(+584.7%) | $167.97 M(+166.4%) |
| Jun 2019 | - | $17.45 M(+58.9%) | $63.05 M(-3.0%) |
| Mar 2019 | - | $10.98 M(-45.4%) | $64.99 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $65.20 M(-9.0%) | $20.10 M(+38.4%) | $65.20 M(+12.2%) |
| Sep 2018 | - | $14.53 M(-25.0%) | $58.09 M(-5.8%) |
| Jun 2018 | - | $19.38 M(+73.1%) | $61.64 M(-1.5%) |
| Mar 2018 | - | $11.20 M(-13.8%) | $62.55 M(-12.7%) |
| Dec 2017 | $71.64 M(+92.6%) | $12.99 M(-28.1%) | $71.64 M(-9.2%) |
| Sep 2017 | - | $18.08 M(-10.9%) | $78.94 M(+1.5%) |
| Jun 2017 | - | $20.29 M(0.0%) | $77.78 M(+35.3%) |
| Mar 2017 | - | $20.29 M(0.0%) | $57.49 M(+54.5%) |
| Dec 2016 | $37.20 M | $20.29 M(+20.0%) | $37.20 M(+120.0%) |
| Sep 2016 | - | $16.91 M | $16.91 M |
FAQ
- What is Jounce Therapeutics annual revenue?
- What is the all time high annual revenue for Jounce Therapeutics?
- What is Jounce Therapeutics annual revenue year-on-year change?
- What is Jounce Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Jounce Therapeutics?
- What is Jounce Therapeutics TTM revenue?
- What is the all time high TTM revenue for Jounce Therapeutics?
What is Jounce Therapeutics annual revenue?
The current annual revenue of JNCE is $82.00 M
What is the all time high annual revenue for Jounce Therapeutics?
Jounce Therapeutics all-time high annual revenue is $147.87 M
What is Jounce Therapeutics annual revenue year-on-year change?
Over the past year, JNCE annual revenue has changed by +$55.09 M (+204.75%)
What is Jounce Therapeutics quarterly revenue?
The current quarterly revenue of JNCE is $82.00 M
What is the all time high quarterly revenue for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly revenue is $119.44 M
What is Jounce Therapeutics TTM revenue?
The current TTM revenue of JNCE is $82.00 M
What is the all time high TTM revenue for Jounce Therapeutics?
Jounce Therapeutics all-time high TTM revenue is $167.97 M